Amethyst Radiotherapy UK has announced the appointment of Sasha Burns as its new Chief Executive Officer (CEO), marking a significant step in the company’s commitment to advancing cancer treatment and expanding its services across the region.
In her new role, Burns will oversee strategic growth, operational management, and the enhancement of patient care services. She will also focus on strengthening partnerships within the healthcare sector and driving innovation in radiotherapy solutions.
Expressing her vision for the company, Burns stated: “I am honored to lead Amethyst Radiotherapy UK at such a pivotal time. My goal is to expand access to cutting-edge cancer treatment, ensuring that patients receive the highest quality care while fostering innovation in radiotherapy.”
Burns brings a wealth of experience to the role, having previously held senior leadership positions in the healthcare and medical technology sectors. Her expertise in healthcare management, strategic development, and patient-centered care makes her a strong addition to Amethyst Radiotherapy’s leadership team.
Her appointment aligns with the company’s mission to provide advanced and accessible radiotherapy treatments, further solidifying its position as a leader in cancer care across the UK.
